Hyperkalemic periodic paralysis. Relationships between changes in plasma water, electrolytes, insulin and catecholamines during attacks.
D000420:Albuterol / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis; D001834:Body Water / Q000032:analysis; D002395:Catecholamines / Q000097:blood*; D002712:Chlorides / Q000097:blood; D004573:Electrolytes / Q000097:blood*; D005934:Glucagon / Q000097:blood; D006400:Hematocrit; D006801:Humans; D006947:Hyperkalemia / Q000097:blood* / Q000188:drug therapy; D007328:Insulin / Q000097:blood*; D008214:Lymphocytes / Q000032:analysis; D010245:Paralyses, Familial Periodic / Q000097:blood* / Q000188:drug therapy; D005082:Physical Exertion; D011188:Potassium / Q000097:blood; D011189:Potassium Chloride / Q000494:pharmacology; D012964:Sodium / Q000097:blood
D001786:Blood Glucose; D001798:Blood Proteins; D002395:Catecholamines; D002712:Chlorides; D004573:Electrolytes; D007328:Insulin; D011189:Potassium Chloride; D005934:Glucagon; D012964:Sodium; D000420:Albuterol; D011188:Potassium